Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Filings indexed 1,264 across all filing types
Latest filing 2013-11-06 Director's Dealing
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2013-11-06 English
Regulatory Filings 2013
Regulatory Filings
2013-10-07 English
Regulatory Filings 2013
Regulatory Filings
2013-08-30 English
FORM 3
Director's Dealing
2013-08-14 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q2 2013
2013-08-06 English
Earnings Release 2013
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions "Item 2.02. Results of Operations and Financial Condition" and states that the company announced financial and operating results for the period ended June 30, 2013. It also references a press release attached as Exhibit 99. The document is relatively short (2351 characters) and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or analysis itself. According to the rules, initial announcements of quarterly or periodical financial results (key highlights only) correspond to the Earnings Release (ER) category. Therefore, this document should be classified as an Earnings Release (ER).
2013-08-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.